Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
1. To investigate the effect of insulin glargine (Lantus™) vs NPH insulin regarding
glycemic control during the early AM (dawn phenomenon) in individuals with type 1
diabetes.
2. To measure hormones implicated in the pathogenesis of the dawn phenomenon in individuals
with type 1 diabetes.